Quantcast

Liver Fibrosis Global Clinical Trials Review, H2, 2013

March 20, 2014

LONDON, March 20, 2014 /PRNewswire/ — Reportbuyer.com just published a new market research report:

Liver Fibrosis Global Clinical Trials Review, H2, 2013

Liver Fibrosis Global Clinical Trials Review, H2, 2013

Summary

GlobalData’s clinical trial report, “Liver Fibrosis Global Clinical Trials Review, H2, 2013″ provides data on the Liver Fibrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liver Fibrosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Liver Fibrosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Liver Fibrosis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Liver Fibrosis 23
Subjects Recruited Over a Period of Time 24

Prominent Sponsors 25
Top Companies Participating in Liver Fibrosis Therapeutics Clinical Trials 27
Prominent Drug Comparison 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Merck & Co., Inc. 30
Clinical Trial Overview of Merck & Co., Inc. 30
Gilead Sciences, Inc. 31
Clinical Trial Overview of Gilead Sciences, Inc. 31
F. Hoffmann-La Roche Ltd. 32
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 32
Pfizer Inc. 33
Clinical Trial Overview of Pfizer Inc. 33
C. H. Boehringer Sohn AG & Co. KG 34
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 34
GlaxoSmithKline plc 35
Clinical Trial Overview of GlaxoSmithKline plc 35
Gilead Sciences 36
Clinical Trial Overview of Gilead Sciences 36
Galectin Therapeutics 37
Clinical Trial Overview of Galectin Therapeutics 37
FibroGen, Inc. 38
Clinical Trial Overview of FibroGen, Inc. 38
CJ Freshway Corporation 39
Clinical Trial Overview of CJ Freshway Corporation 39

Clinical Trial Overview of Top Institutes / Government 40
French National Agency for Research on AIDS and Viral Hepatitis 40
Clinical Trial Overview of French National Agency for Research on AIDS and Viral Hepatitis 40
Assistance Publique – Hopitaux de Paris 41
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 41
The National Institute of Diabetes and Digestive and Kidney Diseases 42
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 42
Imperial College London 43
Clinical Trial Overview of Imperial College London 43
University of Zurich 44
Clinical Trial Overview of University of Zurich 44
Beijing Friendship Hospital 45
Clinical Trial Overview of Beijing Friendship Hospital 45
The National Institute of Allergy and Infectious Diseases 46
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 46
China Medical University Hospital 47
Clinical Trial Overview of China Medical University Hospital 47
Association HGE CHU Bordeaux Sud 48
Clinical Trial Overview of Association HGE CHU Bordeaux Sud 48
302 MILITARY HOSPITAL OF CHINA 49
Clinical Trial Overview of 302 MILITARY HOSPITAL OF CHINA 49
Five Key Clinical Profiles 50
Appendix 72
Abbreviations 72
Definitions 72
Research Methodology 73
Secondary Research 73
About GlobalData 74
Contact Us 74
Disclaimer 74
Source 75

List of Tables

Liver Fibrosis Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7
Liver Fibrosis Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Liver Fibrosis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Liver Fibrosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 10
Liver Fibrosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11
Liver Fibrosis Therapeutics Clinical Trials, North America, Top Countries, 2013* 12
Liver Fibrosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 13
Liver Fibrosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2013* 14
Liver Fibrosis Therapeutics Clinical Trials, BRIC Countries, 2013* 15
Liver Fibrosis Therapeutics Clinical Trials, G7 Countries, 2013* 16
Liver Fibrosis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Liver Fibrosis Therapeutics Clinical Trials, E7 Countries, 2013* 18
Liver Fibrosis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
Liver Fibrosis Therapeutics Market, Global, Clinical Trials by Phase, 2013* 20
Liver Fibrosis Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 21
Liver Fibrosis Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Liver Fibrosis Therapeutics Market, Global, Terminated Clinical Trials, 2013* 23
Liver Fibrosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 24
Liver Fibrosis Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 26
Liver Fibrosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 28
Liver Fibrosis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 29
Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013* 30

Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2013* 31
Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2013* 32
Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 33
Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2013* 34
Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 35
Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, 2013* 36
Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Galectin Therapeutics, 2013* 37
Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by FibroGen, Inc., 2013* 38
Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by CJ Freshway Corporation, 2013* 39
Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by French National Agency for Research on AIDS and Viral Hepatitis, 2013* 40
Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique – Hopitaux de Paris, 2013* 41
Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2013* 42
Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2013* 43
Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2013* 44
Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Beijing Friendship Hospital, 2013* 45
Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2013* 46
Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by China Medical University Hospital, 2013* 47
Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Association HGE CHU Bordeaux Sud, 2013* 48
Liver Fibrosis Therapeutics Clinical Trials Market, Global, Clinical Trials by 302 MILITARY HOSPITAL OF CHINA, 2013* 49

List of Figures

Liver Fibrosis Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 7
Liver Fibrosis Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Liver Fibrosis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Liver Fibrosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 10
Liver Fibrosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 11
Liver Fibrosis Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 12
Liver Fibrosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 13
Liver Fibrosis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2013* 14
Liver Fibrosis Therapeutics Clinical Trials, BRIC Countries (%), 2013* 15
Liver Fibrosis Therapeutics Clinical Trials, G7 Countries (%), 2013* 16
Liver Fibrosis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Liver Fibrosis Therapeutics Clinical Trials, E7 Countries (%), 2013* 18
Liver Fibrosis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
Liver Fibrosis Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 20
Liver Fibrosis Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 21
Liver Fibrosis Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Liver Fibrosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 24
Liver Fibrosis Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 25
Liver Fibrosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 27
Liver Fibrosis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 29
GlobalData Methodology 73

Read the full report:
Liver Fibrosis Global Clinical Trials Review, H2, 2013
http://www.reportbuyer.com/pharma_healthcare/drug_discovery/liver_fibrosis_global_clinical_trials_review_h2_2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer


Source: PR Newswire



comments powered by Disqus